Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,004 public trials 571 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Recruiting

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

NCT05780034

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +30 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • University Hospitals Cleveland Medical Center Cleveland, Ohio, United States
View Trial Details
Recruiting

Limited-duration Teclistamab

NCT05932680

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Columbia University New York, United States
  • Abramson Cancer Center at University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma

NCT05722418

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • CU Anschutz Medical Campus, Anshutz Cancer Pavillion Aurora, Colorado, United States
  • Sylvester Comprehensive Cancer Center, University of Miami Hospital and Clinics Miami, Florida, United States
  • University of Kentucky/ Markey Cancer Center Lexington, Kentucky, United States
View all 16 locations
View Trial Details
Recruiting

Impact of an Early Warning System on the Prognosis of Patients With Hematological Malignancies Receiving Intensive Chemotherapy With or Without Hematopoietic Cell Transplantation.

NCT06409767

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Centre Hospitalier Amiens-Picardie Amiens, France
  • Centre Hospitalier Universitaire d'Angers Angers, France
  • Centre Hospitalier Universitaire Besancon Besançon, France
  • Centre Hospitalier Universitaire Brest Brest, France
View Trial Details

Related conditions